I. Ostmansmith, REDUCTION BY ORAL PROPRANOLOL TREATMENT OF LEFT-VENTRICULAR HYPERTROPHY SECONDARY TO PRESSURE-OVERLOAD IN THE RAT, British Journal of Pharmacology, 116(6), 1995, pp. 2703-2709
1 Studies on cardiac myocyte cell, cultures have postulated a role for
alpha(1)-adrenoceptors and mechanical stretch in the induction of cel
lular changes thought to be important in compensatory cardiac hypertro
phy. However, in vivo work suggests that B-adrenoceptors are important
and the present study was designed to analyse the effect of propranol
ol on the cardiac hypertrophy caused by a pressure-overload in a way t
hat takes account of the effects of propranolol on the work load itsel
f. 2 The compensatory cardiac hypertrophy that develops in response to
experimental coarctation of the aorta was studied in the rat. Pressur
e gradients and total cardiac work load (expressed as rate x pressure
product) were assessed, and the relationship between increasing cardia
c work load and the resulting left ventricular hypertrophy was establi
shed in a control group and compared with left ventricular hypertrophy
in a group treated with a high dose of oral propranolol (80 mg kg(-1)
body weight). 3 In the rats with mean pressure gradients over the coa
rctation in the range of 15-31 mmHg, the animals on control diet showe
d a 38% increase in left ventricular weight/body weight ratio (LV rati
o) and a 30% increase in heart weight/body weight ratio (heart ratio),
whereas rats given high dose oral propranolol-treatment showed increa
ses of only 13% and 9%, respectively. 4 In a second series of rats wit
h a wider range of pressure gradients, the regression lines of LV rati
o versus mean pressure gradient, and of LV ratio versus cardiac work,
were different in the two groups with a slope that was only half as st
eep in the propranolol-treated rats as in the controls. Thus, for the
same increment in cardiac work load, the degree of compensatory cardia
c hypertrophy in propranolol-treated rats was half that observed in co
ntrols. 5 The reduction in compensatory cardiac hypertrophy was not as
sociated with an increase in incidence of congestive heart failure and
the propranolol-treated rats were able to sustain equally high (or hi
gher) degrees of pressure over-load as controls did. 6 It is concluded
that propranolol treatment approximately halves the compensatory card
iac hypertrophy occurring in response to a left ventricular pressure o
ver-load by a mechanism independent of its effect on cardiac work load
. This finding provides further support for the view that noradrenalin
e released from sympathetic nerve terminals in the heart exerts a trop
hic effect on cardiac myocytes, and that the sympathetic nervous syste
m may be the final common pathway in many forms of compensatory cardia
c hypertrophy. In contrast to in vitro models, this effect appears to
be largely mediated via beta-adrenoceptors in the intact animal.